F. Brimo
Associate Professor
DEPARTMENT OF PATHOLOGY
McGill University
Canada
Biography
Dr. Fadi Brimo's is a Staff pathologist at the Montreal General Hospital who specializes in Genito-Urinary Pathology and Cytology.
Research Interest
Morphological, clinical, and basic science studies related to tumors of the Genitourinary tract. The clinical and morphological studies areobservational or outcome-based and address issues impacting diagnostic surgical Pathology, including classification of tumors, original descriptions of histopathologic entities and the development of prognostic biomarkers using tissue microarrays of prostate, bladder and kidney cancer. The basic science work involves collaborations as primary or co-investigator with other McGill clinical departments and research institutions using single nucleotide polymorphism (SNP)-arrays or Fluorescence in situ hybridization (FISH)-assays applied to prostatic and renal carcinoma in the intent of achieving better characterization of the disease at the morphological and prognostic levels.
Publications
-
Neoadjuvant Chemotherapy-Related Histological Changes in Radical Cystectomy: Assessment Accuracy and Prediction of Response. H.Wang, S. Solanki, S. Traboulsi, W. Kassouf, F.Brimo. Accepted in Human Pathology.
-
Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA). W. Kassouf, A. Aprikian, P. Black, G. Kulkarni, J. Izawa, L. Eapen, A. Fairey, A. So, S. North, R. Rendon, S.S. Sridhar, T. Alam, F. Brimo, N. Blais, C. Booth, J. Chin, P. Chung, D. Drachenberg, Y. Fradet, M. Jewett, R.Moore, C. Morash, B. Shayegan, G. Gotto, N. Fleshner, F. Saad, D. R. Siemens. Can Urol Assoc J. 2016 Feb; 10(1-2): E46-80.
